PCSK9 Inhibitors and Risk of Aortic Stenosis in Atherosclerotic Cardiovascular Disease. [PDF]
Wu JY +4 more
europepmc +1 more source
Gene Silencing of ANGPTL3 Induces PCSK9: Exploring the Biological Significance in the Hepatoma Huh7 Cell Line. [PDF]
Rossi I +8 more
europepmc +1 more source
PCSK9 at the intersection of lipid metabolism, immunometabolism, and psychiatric disorders: A narrative review. [PDF]
van Bruggen FH, McIntyre RS.
europepmc +1 more source
Therapeutic monoclonal antibodies for diabetic kidney disease: a narrative review from basic mechanisms to clinical evidence. [PDF]
Yang XH, Liu Y, Fu CS, Jin HM, Ye ZB.
europepmc +1 more source
From particle count to residence time: a kinetic framework for atherogenic risk. [PDF]
Larronde E.
europepmc +1 more source
PCSK9 inhibition alleviates sepsis-induced myocardial dysfunction by facilitating PINK1/parkin-associated mitophagy. [PDF]
Lin J +8 more
europepmc +1 more source
Alliin Regulates Intracellular Cholesterol Metabolism Through the PCSK9/LDLR Axis in Ox-LDL-Induced HepG2 Cells: A Proteomics Study. [PDF]
Tang Y, Liu X.
europepmc +1 more source
PCSK9 Inhibitors Increase CD34+ But Not Other Endothelial Progenitor Cells in Patients with Chronic Coronary Disease and Increased Lp(a) Values. [PDF]
Ugovšek S +11 more
europepmc +1 more source
PCSK9 inhibitors do not increase cognitive risk. [PDF]
Ni D +6 more
europepmc +1 more source

